Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Shanghai Henlius Biotechnology
Pharma
Apellis hit with yet another eye drug snub in Europe
Amid a parade of regulatory endorsements in Europe, Apellis’ ophthalmology prospect pegcetacoplan has been left in the cold once again.
Fraiser Kansteiner
Sep 20, 2024 10:06am
Daiichi-Merck, Wegovy, Takeda CEO—Fierce Pharma Asia
Jun 28, 2024 8:40am
With big discounts, 100+ drugs win national coverage in China
Jan 18, 2023 2:30pm
Biocon, Henlius, Takeda and more—Fierce Pharma Asia
Sep 2, 2022 8:55am
Henlius CEO scouts for US PD-1 partner amid Fosun unit's pivot
Aug 30, 2022 1:30am
Daiichi, BeiGene, Kyowa Kirin—Fierce Pharma Asia
Jun 17, 2022 10:15am
